Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaëtan MacGrogan

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Breast Cancer Research and Treatment|September 19, 2019
Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapyClémence Pinard, Marc Debled, Houda Ben Rejeb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Epithelial atypia: a marker risk of concomitant or subsequent breast carcinoma?Isabelle de Mascarel, Gaëtan MacGrogan, Anne Vincent-Salomon, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 6, 2022
Neoadjuvant chemotherapy and radiotherapy for locally advanced breast cancer: Safety and efficacy of reverse sequence compared to standard technique?Mathilde Maire, Marc Debled, Adeline Petit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Time for reappraisal of progesterone-receptor testing in breast cancer managementGaëtan MacGrogan, Isabelle de Mascarel, Ghyslaine Sierankowski, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 20, 2013
YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlationsSabrina Croce, Isabelle Hostein, Agnes Ribeiro, et al.
Breast Cancer Research : BCR|February 19, 2016
LIN7A is a major determinant of cell-polarity defects in breast carcinomasNadège Gruel, Laetitia Fuhrmann, Catalina Lodillinsky, et al.
The American Journal of Surgical Pathology|July 3, 2015
SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomasMarie Karanian-Philippe, Valérie Velasco, Michel Longy, et al.
The American Journal of Surgical Pathology|August 21, 2015
Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene FusionMarie Del Castillo, Frédéric Chibon, Laurent Arnould, et al.
International Journal of Cancer|January 16, 2013
Comprehensive analysis of PTEN status in breast carcinomasNatalie Jones, Françoise Bonnet, Sana Sfar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 21, 2019
Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutationsJulie Massé, Caroline Truntzer, Romain Boidot, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Breast Cancer Research and Treatment|September 19, 2019
Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapyClémence Pinard, Marc Debled, Houda Ben Rejeb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Epithelial atypia: a marker risk of concomitant or subsequent breast carcinoma?Isabelle de Mascarel, Gaëtan MacGrogan, Anne Vincent-Salomon, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 6, 2022
Neoadjuvant chemotherapy and radiotherapy for locally advanced breast cancer: Safety and efficacy of reverse sequence compared to standard technique?Mathilde Maire, Marc Debled, Adeline Petit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Time for reappraisal of progesterone-receptor testing in breast cancer managementGaëtan MacGrogan, Isabelle de Mascarel, Ghyslaine Sierankowski, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 20, 2013
YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlationsSabrina Croce, Isabelle Hostein, Agnes Ribeiro, et al.
Breast Cancer Research : BCR|February 19, 2016
LIN7A is a major determinant of cell-polarity defects in breast carcinomasNadège Gruel, Laetitia Fuhrmann, Catalina Lodillinsky, et al.
The American Journal of Surgical Pathology|July 3, 2015
SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomasMarie Karanian-Philippe, Valérie Velasco, Michel Longy, et al.
The American Journal of Surgical Pathology|August 21, 2015
Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene FusionMarie Del Castillo, Frédéric Chibon, Laurent Arnould, et al.
International Journal of Cancer|January 16, 2013
Comprehensive analysis of PTEN status in breast carcinomasNatalie Jones, Françoise Bonnet, Sana Sfar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 21, 2019
Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutationsJulie Massé, Caroline Truntzer, Romain Boidot, et al.
Pageof 8